A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors

A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors

Cancer vaccines represent a promising personalized therapeutic approach to treating cancer. Here, the authors report the efficacy in a metastatic model of a cancer vaccine-mediated postoperative immunotherapy, based on the coencapsulation of the JQ1 and a photosensitizer ICG together with inactivate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tingting Wang, Dangge Wang, Haijun Yu, Bing Feng, Fangyuan Zhou, Hanwu Zhang, Lei Zhou, Shi Jiao, Yaping Li
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/f199e800202e4de7bad91d4e281d2a23
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f199e800202e4de7bad91d4e281d2a23
record_format dspace
spelling oai:doaj.org-article:f199e800202e4de7bad91d4e281d2a232021-12-02T17:33:06ZA cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors10.1038/s41467-018-03915-42041-1723https://doaj.org/article/f199e800202e4de7bad91d4e281d2a232018-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-03915-4https://doaj.org/toc/2041-1723Cancer vaccines represent a promising personalized therapeutic approach to treating cancer. Here, the authors report the efficacy in a metastatic model of a cancer vaccine-mediated postoperative immunotherapy, based on the coencapsulation of the JQ1 and a photosensitizer ICG together with inactivated tumor cells into a hydrogel matrix.Tingting WangDangge WangHaijun YuBing FengFangyuan ZhouHanwu ZhangLei ZhouShi JiaoYaping LiNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Tingting Wang
Dangge Wang
Haijun Yu
Bing Feng
Fangyuan Zhou
Hanwu Zhang
Lei Zhou
Shi Jiao
Yaping Li
A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
description Cancer vaccines represent a promising personalized therapeutic approach to treating cancer. Here, the authors report the efficacy in a metastatic model of a cancer vaccine-mediated postoperative immunotherapy, based on the coencapsulation of the JQ1 and a photosensitizer ICG together with inactivated tumor cells into a hydrogel matrix.
format article
author Tingting Wang
Dangge Wang
Haijun Yu
Bing Feng
Fangyuan Zhou
Hanwu Zhang
Lei Zhou
Shi Jiao
Yaping Li
author_facet Tingting Wang
Dangge Wang
Haijun Yu
Bing Feng
Fangyuan Zhou
Hanwu Zhang
Lei Zhou
Shi Jiao
Yaping Li
author_sort Tingting Wang
title A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
title_short A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
title_full A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
title_fullStr A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
title_full_unstemmed A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
title_sort cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/f199e800202e4de7bad91d4e281d2a23
work_keys_str_mv AT tingtingwang acancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT danggewang acancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT haijunyu acancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT bingfeng acancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT fangyuanzhou acancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT hanwuzhang acancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT leizhou acancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT shijiao acancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT yapingli acancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT tingtingwang cancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT danggewang cancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT haijunyu cancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT bingfeng cancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT fangyuanzhou cancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT hanwuzhang cancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT leizhou cancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT shijiao cancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
AT yapingli cancervaccinemediatedpostoperativeimmunotherapyforrecurrentandmetastatictumors
_version_ 1718380097706131456

Ejemplares similares